TRPV2 and glioblastoma: Patients with high TRPV2 interactome expression (high-risk scores) had shorter median OS than patients with low expression (low-risk scores) in GBM (multivariate Cox analysis points to risk score as an independent prognostic factor, p < 0.001 log-rank test, Figure 4A).